Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yousuke Kamiya

Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial

Journal of Asthma and Allergy

English

Reduction Disintegration Behavior of Iron Ore Sinter Under High H2 and H2O Conditions

ISIJ International

Mechanics of Materials

Alloys

Materials Chemistry

Metals

Mechanical Engineering

2012

English

Related publications

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

English

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

European Respiratory Journal

English

Fluticasone Furoate/Vilanterol Once Daily Improves Night-Time Awakenings in Asthma Patients With Night Symptoms; Post-Hoc Analyses of Three Randomized Controlled Trials

English

Integrated Safety and Efficacy Analysis of Once-Daily Fluticasone Furoate for the Treatment of Asthma

English

Safety and Tolerability of the Novel Inhaled Corticosteroid Fluticasone Furoate in Combination With the Β2agonist Vilanterol Administered Once Daily for 52 Weeks in Patients ≥12 Years Old With Asthma: A Randomised Trial

English

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Pulmonary Pharmacology and Therapeutics

English

Single-Inhaler Triple Therapy Utilizing the Once-Daily Combination of Fluticasone Furoate, Umeclidinium and Vilanterol in the Management of COPD: The Current Evidence Base and Future Prospects

Therapeutic Advances in Respiratory Disease

English

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

English

PRS47 Optima Model-Based Cost-Utility Analysis of Fixed Combination Salmeterol/Fluticasone Versus Non-Fixed Combination Budesonide/Formoterol in One Pack for Bronchial Asthma Treatment

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Yousuke Kamiya

Once-Daily Fluticasone Furoate/Vilanterol Combination Versus Twice-Daily Budesonide/Formoterol Combination in the Treatment of Controlled Stable Asthma: A Randomized Crossover Trial

Reduction Disintegration Behavior of Iron Ore Sinter Under High H2 and H2O Conditions

Related publications

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

A Comparison of the Efficacy and Safety of Once-Daily Fluticasone Furoate/Vilanterol With Twice-Daily Fluticasone Propionate/Salmeterol in Moderate to Very Severe COPD

Fluticasone Furoate/Vilanterol Once Daily Improves Night-Time Awakenings in Asthma Patients With Night Symptoms; Post-Hoc Analyses of Three Randomized Controlled Trials

Integrated Safety and Efficacy Analysis of Once-Daily Fluticasone Furoate for the Treatment of Asthma

Safety and Tolerability of the Novel Inhaled Corticosteroid Fluticasone Furoate in Combination With the Β2agonist Vilanterol Administered Once Daily for 52 Weeks in Patients ≥12 Years Old With Asthma: A Randomised Trial

Efficacy and Safety of Ciclesonide Once Daily and Fluticasone Propionate Twice Daily in Children With Asthma

Single-Inhaler Triple Therapy Utilizing the Once-Daily Combination of Fluticasone Furoate, Umeclidinium and Vilanterol in the Management of COPD: The Current Evidence Base and Future Prospects

Efficacy of a New Once-Daily Long-Acting Inhaled 2-Agonist Indacaterol Versus Twice-Daily Formoterol in COPD

PRS47 Optima Model-Based Cost-Utility Analysis of Fixed Combination Salmeterol/Fluticasone Versus Non-Fixed Combination Budesonide/Formoterol in One Pack for Bronchial Asthma Treatment